Clinical trial Recruiting at 1 site Interventional Ages 21 and up

Using patterned non-invasive brain stimulation (iTBS) to improve hand strength after chronic stroke

Official title: Evaluation of 3 Patterned rTMS Stimulation Dosage on Corticospinal Excitability and Motor Learning in Stroke Patients

Run by Duke University · NCT06765642 · Data updated 2026-11-12

This trial will test whether a high-dose patterned non-invasive brain stimulation (iTBS) can help people with chronic stroke regain hand muscle strength and motor control.

Quick facts

Study typeInterventional
Ages21 Years and up
SexAll
Enrollment26 (estimated)
SponsorDuke University
Academic / other
Locations1 site (Durham, North Carolina)
StatusRecruiting
StartedJune 9, 2025
Main results expectedApril 13, 2027
Study endsApril 30, 2027
Registry record updatedMay 22, 2026
Trial IDNCT06765642 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 21 or older with a single ischemic or hemorrhagic stroke at least six months prior, unilateral arm weakness (FM-UE score ≤62/64), and an inducible motor threshold from the affected FDI muscle.

Probably not a fit

Patients with bilateral strokes, other neuromuscular disorders affecting the arm, uncontrolled neuropsychiatric disease or dementia, or uncontrolled hypertension are unlikely to be eligible or to receive benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Researchers will compare a conventional intermittent theta-burst stimulation (iTBS600) protocol to two high-dose protocols (FiTBS2400 applied to one focal site and DiTBS2400 applied across four sites) delivered to the damaged hemisphere in people at least six months after a first stroke. Outcomes include measures of corticospinal excitability and motor performance of the affected hand, with motor thresholds recorded from the first dorsal interosseous muscle. The study uses repeated non-invasive transcranial magnetic stimulation sessions and standardized motor testing to quantify neuromotor changes. Results aim to determine whether higher total pulse doses or broader versus focal stimulation produce greater neural plasticity and functional gains.

Why it matters

Potential benefit: If successful, this approach could increase hand strength and improve functional use of the affected arm by enhancing corticospinal plasticity.

How similar studies have gone: Previous rTMS and iTBS studies after stroke have shown promising but mixed motor benefits, while the specific high-dose focal versus diffuse iTBS protocols tested here are relatively novel and less well studied.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion criteria:

1. Age \>=21 years old of any race or gender
2. First-ever ischemic or hemorrhagic stroke (neuroimaging verified) at least 3 months from stroke onset
3. Unilateral arm weakness measured by FM-UM scale \<= 62 out of 66
4. Inducible rest motor threshold and testing motor threshold recorded from the affected first dorsal interosseous (FDI) muscle from the study subject

Exclusion criteria

1. Bilateral strokes (infarcts and/or hematoma)
2. Other co-existent neuromuscular disorders affecting upper extremity motor impairment.
3. History of medically uncontrolled depression or other neuropsychiatric disorders despite medications either before or after a stroke that may affect the subject's ability to participate in the study.
4. Uncontrolled hypertension despite medical treatment(s) at the time of randomization, defined as SBP≥185 mmHg or DBP≥110 mmHg (patient can be treated, reassessed and randomized later).
5. Presence of any MRI/rTMS risk factors including but not limited to:

   1. an electrically, magnetically, or mechanically activated metallic or nonmetallic implant including cardiac pacemaker, intracerebral vascular clips or any other electrically sensitive support system.
   2. a non-fixed metallic part in any part of the body, including a previous metallic injury to the eye.
   3. history of seizure disorder before stroke or seizure after stroke.
   4. preexisting scalp lesion or bone defect or hemicraniectomy.
6. Concurrent enrollment in another interventional stroke recovery study.
7. Concerns that the subject cannot comply with study procedures and visits.
8. Pregnant individuals

Where it's running

  • Duke University Medical Center
    Durham, North Carolina, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.